OBJECTIVEdThe recommended HbA 1c diagnostic categories remain controversial and their utility in doubt in pediatrics. We hypothesized that alterations in the pathophysiologic mechanisms of type 2 diabetes may be evident in the American Diabetes Association recommended at-risk/prediabetes category (HbA 1c 5.7 to ,6.5%).
G lycated hemoglobin (HbA 1c ) is used to monitor diabetes control in diagnosed patients (1) . In 2009, an international expert committee recommended that HbA 1c also be used for diagnosis of diabetes and risk of diabetes (1) . Subsequently, HbA 1c diagnostic cutoffs were incorporated into the 2010 American Diabetes Association (ADA) guidelines for diabetes (HbA 1c $6.5%) and prediabetes (HbA 1c 5.7 to ,6.5%) (2) . Unlike glycemic measures (e.g., fasting glucose, oral glucose tolerance test [OGTT] ), the HbA 1c may be performed in the nonfasting state (2) . However, adoption of these proposed criteria continues to be debated (3) (4) (5) (6) (7) (8) . In crosssectional studies of adults, the HbA 1c criteria had lower sensitivity for diabetes diagnosis compared with OGTT (6) or a single fasting plasma glucose (9) . But, the sensitivity of the HbA 1c criteria improved when compared with repeated fasting plasma glucose samples (3 years apart), and the combination of fasting glucose and HbA 1c provided the greatest predictive value for 10-year diabetes risk compared with fasting glucose alone (single or repeated) (9) . Furthermore, in a longitudinal study, HbA 1c identified fewer cases of prediabetes at baseline, but had similar predictive value for progression to diabetes as fasting glucose (;5-year follow-up) (10) . Accordingly, recent pediatric studies indicate that HbA 1c identifies fewer adolescents with diabetes/prediabetes compared with glycemic measures (4, 5, 11) . However, similar to adults, HbA 1c improved the predictive value of glycemic measures alone after a 2-year follow-up in adolescents (5) . Because glycemic measures of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are linked to impaired insulin secretion relative to insulin sensitivity, conferring an increased risk of type 2 diabetes (12,13), we hypothesized that alterations in the pathophysiologic mechanisms of type 2 diabetes could be detected in the ADA recommended at-risk/prediabetes category (HbA 1c 5.7 to ,6.5%). Therefore, we aimed to evaluate in vivo insulin sensitivity and b-cell function in overweight/ obese youth categorized according to the 2010 ADA HbA 1c criteria (2) as normal versus prediabetes.
RESEARCH DESIGN AND
METHODSdApproval by the Institutional Review Board of the University of Pittsburgh, parental consent and child assent were obtained prior to any research procedure. A total of 204 overweight/ obese youth (according to age-and sexspecific BMI percentiles [14] ) (89 African Americans and 115 Caucasians; 88 males and 116 females; ages 9 to ,20 years old; Tanner stage II-V) (15) who had complete hyperinsulinemic-euglycemic and hyperglycemic clamp data obtained while participating in our ongoing studies of National Institutes of Health grants "Childhood Metabolic Markers of Adult Morbidity in Blacks" and "Childhood Insulin Resistance" were included. Some of these participants' data have been reported along with details of our recruitment and screening procedures (13, (16) (17) (18) (20, 21) . Four baseline blood samples were collected (230 to 0 min) for determination of glucose, insulin, and isotopic enrichment of glucose prior to the initiation (0 min) of the clamp. On a separate occasion, 1 to 3 weeks apart, and in random order, a 2-h hyperglycemic clamp (;225 mg/dL) was performed (12, 13, 22) . Either the day preceding one of the clamp procedures or on a separate visit within a 1-to 3-week period, a 2-h OGTT (1.75 g/kg glucola, maximum 75 g) was performed in 142 participants (23, 24) . Normal versus impaired glycemia was defined according to standards for fasting or 2-h OGTT glucose (2).
Percent body fat was measured with dual energy X-ray absorptiometry and abdominal visceral adipose tissue (VAT) with computed tomography in 154 subjects and magnetic resonance imaging in 50 subjects (17, 21) .
Biochemical analyses
Plasma glucose was measured by the glucose oxidase method (Yellow Springs Instrument Co., Yellow Springs, OH), and insulin by a commercial radioimmunoassay (catalog number 1011; LINCO Research, St. Charles, MO) (13) . HbA 1c was measured by high-performance liquid chromatography (Tosoh Medics), and "normal" was defined as HbA 1c ,5.7% and "prediabetes" as HbA 1c $5.7% to ,6.5% according to ADA criteria (2) . Deuterium enrichment of glucose in the plasma was determined on a Hewlett-Packard 5971 mass spectrometer coupled to a 5890 series II gas chromatograph (Hewlett-Packard) (20, 21) .
Calculations
Fasting HGP was measured during the last 30 min of the 2-h baseline isotope infusion and hepatic insulin sensitivity (HIS) was calculated as 1,000/(HGP 3 fasting insulin) (12, 20) . Peripheral insulin sensitivity (mg/kg/min per mU/mL) was calculated during the last 30 min (150-180 min) of the hyperinsulinemic-euglycemic clamp (12, 13, 19, 22) . First-phase insulin (mU/mL) was calculated as the mean insulin concentration at times 2.5, 5, 7.5, 10, and 12.5 min during the hyperglycemic clamp (21, 25) . b-Cell function relative to insulin sensitivity, the disposition index (DI; mg/kg/min), was calculated as the product of insulin sensitivity and first-phase insulin (13, 16) . In the subset of 142 participants with OGTT, area under the curve (AUC) for glucose and insulin was calculated by the trapezoidal rule and the insulinogenic index (DI 30 /DG 30 ) and the oral DI (oDI) as before (24) (25) (26) .
Statistical analyses
Differences in categorical variables were determined by x 2 analysis, and differences in continuous variables were determined by two-tailed t test or by ANCOVA adjusting for race. Differences in insulin sensitivity, first-phase insulin, and DI across HbA 1c categories (normal versus prediabetes) were determined by twotailed t test and also by ANCOVA adjusting for race and adiposity (BMI, percent body fat, or VAT). Overall differences across subgroups of NGT versus dysglycemia by OGTT and normal versus prediabetes by HbA 1 c were determined using ANCOVA, adjusting for race and VAT in SPSS (PASW 18; SPSS Inc., Chicago, IL). Data are presented as mean 6 SE. Adjusted P value is the significance after adjusting for race. AA, African American; C, Caucasian.
A P value of #0.05 was considered statistically significant, and P # 0.10 was considered a trend. (Table 1 ). These differences persisted after adjusting for race and percent body fat. Peripheral insulin sensitivity was lower in the prediabetes versus normal HbA 1c category before and after adjustment for race (P = 0.004; data not shown), but was not different after additional adjustment for adiposity (Fig. 1A) . First-phase insulin was not different between the two groups; however, DI, b-cell function relative to insulin sensitivity, was significantly lower in the prediabetes versus normal HbA 1c category after adjusting for race and adiposity (BMI, percent body fat, or VAT; Fig. 1A ). In the subset of participants with OGTT-derived indices (Fig. 1B) (Fig. 2) .
RESULTS

Subject characteristics
CONCLUSIONSdThe current study demonstrates that overweight/obese adolescents meeting the ADA HbA 1c diagnostic criteria (2) for prediabetes have evidence of impaired b-cell function relative to insulin sensitivity, a metabolic signal for heightened risk of type 2 diabetes (27) . This finding persisted after adjustment for race and for the greater adiposity in the youth with elevated HbA 1c . These data support our hypothesis that alterations in the pathophysiologic mechanisms of type 2 diabetes are evident in the ADA-recommended at-risk/prediabetes category (HbA 1c 5.7 to ,6.5%).
Since the release of the HbA 1c -based diagnostic criteria for prediabetes/diabetes by the ADA in 2010 (2), reports of adults and some in pediatrics have concluded that HbA 1c is inferior to glycemic measures for diagnostic purposes (4) (5) (6) 11) . These studies evaluated the diagnostic sensitivity and specificity of HbA 1c compared with glycemic measures, treating the latter as the gold standard. One such study determined that the inferior sensitivity of the recommended HbA 1c cutoff compared with OGTT was worse for adolescents than for adults (4) . However, although these studies evaluated equivalence of the new HbA 1c criteria compared with glycemic criteria, they did not evaluate metabolic characteristics linked to future diabetes risk. Moreover, as noted in a Comment published in care.diabetesjournals.org DIABETES CARE, VOLUME 35, DECEMBER 2012 2561
Diabetes Care, "it is a fallacy that the OGTT is a gold standard. . . if you define one test as a gold standard, all comparators will be inferior" (28) . Indeed, in longitudinal studies, HbA 1c criteria predicted a similar rate of progression to diabetes as did IFG, and the combination of fasting glucose and HbA 1c provided the greatest predictive value of diabetes incidence (9,10). The DI, which expresses b-cell function relative to insulin sensitivity, is an established metabolic predictor of progression to diabetes (12,13,29-31 ). Numerous longitudinal studies in adults have demonstrated the predictive value of DI (including oral DI) for the future development of diabetes (27, 29, 32, 33) . In addition, we (12, 13) and others (30, 31) have reported progressively declining DI across the spectrum of glycemia from normal to IFG and/or IGT to type 2 diabetes in youth. Therefore, even though the ADA HbA 1c diagnostic criteria have a lower sensitivity for diagnosis of prediabetes when compared with glycemic measures, we show in this study that these criteria are consistent with greater metabolic risk (lower clamp DI, oral DI, and insulinogenic index) using sensitive metabolic assessments.
Evaluating HbA 1c and glycemia together, youth with normal HbA 1c combined with normoglycemia had the highest DI compared with the other groups, and DI seemed to be lowest overall in the group with both elevated HbA 1c and dysglycemia (Fig. 2) . Moreover, rates of dysglycemia were higher in the prediabetes (41%) versus normal HbA 1c category (27%) (Fig. 2) . Overall, these data support the use of HbA 1c to identify youth with lower b-cell function for epidemiological observational and/or interventional studies of overweight/obese youth and progression to type 2 diabetes. However, the independent use of HbA 1c for clinical diagnostic purposes may be premature. Collectively, these observations indicate that the combination of HbA 1c and a glycemic measure may best pinpoint subjects at lowest or greatest risk of eventual diabetes (9, 10) . Longitudinal studies will be necessary to determine whether there are differences in rates of the development of diabetes between youth with normal HbA 1c and dysglycemia versus those with elevated HbA 1c and dysglycemia.
A potential challenge in the application of the HbA 1c is the higher HbA 1c in African Americans than Caucasians, present in our study and reported by others (5, 34) . Racial differences in HbA 1c result in more African Americans and fewer Caucasians being identified as having prediabetes using HbA 1c compared with glycemic criteria (6, 7) . Potentially, the ADA-recommended cut points may not be appropriate for all racial groups, and exploration of cut points customized for race/ethnicity in larger scale studies may be warranted. Regardless, in this study, we report impaired b-cell function as well as lower peripheral and hepatic insulin sensitivity in youth with elevated versus normal HbA 1c , independent of the effects of race.
Strengths of the current investigation include the simultaneous assessment of HbA 1c , clamp-measured in vivo insulin sensitivity and b-cell function, and an OGTT in a large group of adolescents. A limitation of this report is that we included only overweight/obese adolescents, and our population does not represent other minority groups (e.g., Hispanics) in which the utility of HbA 1c may vary (34) . Lastly, the number of youth with elevated HbA 1c and dysglycemia is somewhat limited.
In conclusion, the recently recommended HbA 1c criteria coincide with lower peripheral and hepatic insulin sensitivity and lower b-cell function relative to insulin sensitivity in overweight/obese adolescents. Larger and longitudinal studies are required to more thoroughly investigate the interplay of race within categories of dysglycemia and HbA 1c in relation to metabolic risk factors for diabetes (e.g., DI). Although controversy is likely to continue surrounding the adoption of HbA 1c -based criteria for the diagnosis of prediabetes and diabetes in youth, these data support that the ADA HbA 1c criteria for prediabetes correspond to impaired b-cell function in overweight/ obese youth, a metabolic marker of heightened type 2 diabetes risk. No potential conflicts of interest relevant to this article were reported. L.A.S. analyzed the data and first-authored the manuscript. S.F.M. provided technical support for data analysis, editing, and review of the manuscript. S.L., H.T., and F.B. contributed research participants and data. L.F. managed the data entry and database maintenance. S.A.A. provided the study concept and design; acquired data; obtained funding; provided administrative, technical, and material support; supervised the study; and critically reviewed and edited the manuscript. S.A.A. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
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